AI data under the microscope: Accelerating and securing the AI data supply chain for the health and biopharmaceutical sectors

This report examines how health and biopharmaceutical companies interact with the data components of the AI supply chain, and how a fractured global regulatory landscape shapes their ability to innovate responsibly. It maps seven data components, from training data to model weights, APIs, and SDKs, against real-world use cases spanning drug discovery, cancer diagnostics, and cross-border genomic research, explores fourteen exemplative regulatory regimes across the United States, the European Union, China, and India, and assesses the tensions, open questions, and policy recommendations that wil